» Articles » PMID: 12533032

Autoimmune Phenomena in Patients with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Overview
Journal Leuk Lymphoma
Specialties Hematology
Oncology
Date 2003 Jan 21
PMID 12533032
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Autoimmune paraneoplastic syndromes are commonly encountered in patients with myelodysplastic syndromes (MDS). A review of case reports and small series suggest as many as 10% of MDS patients may experience various autoimmune syndromes. Clinical manifestations of such phenomena may include an acute systemic vasculitic syndrome, skin vasculitis, fever, arthritis, pulmonary infiltrates, peripheral polyneuropathy, inflammatory bowel disease, glomerulonephritis, and even classical connective tissue disorders, such as relapsing polychondritis. On the other hand, asymptomatic immunologic abnormalities have also been reported in these patients. These autoimmune manifestations frequently respond to immunosuppressive agents including steroids and occasional hematologic responses to steroid therapy have also been reported. We report five patients with history of MDS who manifested different spectrums of autoimmune phenomena including: pyoderma gangrenosum (PG), vasculitis, Coombs negative hemolytic anemia, idiopathic thrombocytopenia, and chronic inflammatory demyelinating polyneuropathy (CIDP). We also review the incidence, nature, course and response to therapy of these manifestations and discuss potential pathogenic mechanisms.

Citing Articles

Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.

Tazoe K, Harada N, Makuuchi Y, Kuno M, Takakuwa T, Okamura H Ann Hematol. 2024; 103(6):2059-2072.

PMID: 38662207 DOI: 10.1007/s00277-024-05772-2.


Autoimmune diseases and myelodysplastic syndromes.

Cheffai A, Kechida M Reumatologia. 2024; 62(1):52-57.

PMID: 38558894 PMC: 10979376. DOI: 10.5114/reum/184157.


Kidney and Urinary Tract Involvement in Chronic Myelomonocytic Leukemia.

Attieh R, Begum F, Chitty D, Izzedine H, Jhaveri K Kidney Med. 2024; 6(2):100769.

PMID: 38313809 PMC: 10837097. DOI: 10.1016/j.xkme.2023.100769.


Clinical, Histopathological and Molecular Spectrum of Cutaneous Lesions in Myelodysplastic Syndrome and Myeloproliferative Neoplasms (MDS/MPN): An Integrative Review.

Prieto-Torres L, Requena L, Rodriguez-Pinilla S Cancers (Basel). 2023; 15(24).

PMID: 38136431 PMC: 10742063. DOI: 10.3390/cancers15245888.


Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease.

Lafargue M, Bobot M, Rennke H, Essig M, Carre M, Mercadal L Kidney Int Rep. 2023; 8(12):2733-2741.

PMID: 38106568 PMC: 10719588. DOI: 10.1016/j.ekir.2023.09.005.